Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.04B |
| 2 |
Chevron
CVX
|
+$820M |
| 3 |
Shopify
SHOP
|
+$599M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$539M |
| 5 |
Meta Platforms (Facebook)
META
|
+$479M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$675M |
| 2 |
Tesla
TSLA
|
+$661M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$633M |
| 4 |
Verizon
VZ
|
+$533M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$377M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.47% |
| 2 | Technology | 16.84% |
| 3 | Consumer Staples | 11.12% |
| 4 | Consumer Discretionary | 10.18% |
| 5 | Financials | 8.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
Burford Capital
BUR
$968M
| $1.18M | ﹤0.01% |
117,000
-111,300
| -49% | -$977K |
|
|
KLRS
2602
Kalaris Therapeutics
KLRS
$92.4M
| $1.18M | ﹤0.01% |
13,117
+10,808
| +468% | +$1.13M |
|
2603
Cass Information Systems
CASS
$750M
| $1.18M | ﹤0.01% |
34,760
-8,700
| -20% | -$312K |
|
2604
MGIC Investment
MTG
$6.29B
| $1.17M | ﹤0.01% |
+93,100
| New | +$1.22M |
|
|
DCPH
2605
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $1.17M | ﹤0.01% |
+88,900
| New | +$981K |
|
|
TWOU
2606
DELISTED
2U Inc
TWOU
| $1.17M | ﹤0.01% |
3,720
+253
| +7% | +$78.1K |
|
2607
iShares MSCI Mexico ETF
EWW
$1.87B
| $1.17M | ﹤0.01% |
25,000
-169,793
| -87% | -$8.51M |
|
2608
Olema Pharmaceuticals
OLMA
$913M
| $1.17M | ﹤0.01% |
286,134
+38,802
| +16% | +$123K |
|
2609
Pampa Energía
PAM
$4.26B
| $1.16M | ﹤0.01% |
56,860
-20,000
| -26% | -$443K |
|
|
TEN
2610
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
| $1.16M | ﹤0.01% |
67,717
-7,483
| -10% | -$126K |
|
2611
TAT Technologies
TATT
$508M
| $1.16M | ﹤0.01% |
203,600
-2,900
| -1% | -$17.3K |
|
|
ORTX
2612
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $1.16M | ﹤0.01% |
198,629
+117,226
| +144% | +$661K |
|
2613
Digi International
DGII
$3.23B
| $1.16M | ﹤0.01% |
47,800
-74,884
| -61% | -$1.62M |
|
|
AKRO
2614
DELISTED
Akero Therapeutics
AKRO
| $1.15M | ﹤0.01% |
121,800
+68,700
| +129% | +$716K |
|
2615
Vertex
VERX
$2.15B
| $1.15M | ﹤0.01% |
101,300
-15,900
| -14% | -$201K |
|
|
LUCK
2616
Lucky Strike Entertainment
LUCK
$937M
| $1.15M | ﹤0.01% |
+108,200
| New | +$1.15M |
|
|
PARAA
2617
DELISTED
Paramount Global Class A
PARAA
| $1.15M | ﹤0.01% |
42,003
-8,200
| -16% | -$270K |
|
2618
Cactus
WHD
$5.78B
| $1.14M | ﹤0.01% |
28,400
-8,800
| -24% | -$443K |
|
|
RVLP
2619
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
| $1.14M | ﹤0.01% |
840,507
-146,216
| -15% | -$212K |
|
|
OSG
2620
DELISTED
Overseas Shipholding Group Inc.
OSG
| $1.14M | ﹤0.01% |
554,553
-222,126
| -29% | -$476K |
|
|
UBP
2621
DELISTED
Urstadt Biddle Properties Inc.
UBP
| $1.14M | ﹤0.01% |
65,525
-975
| -1% | -$15.9K |
|
|
WTT
2622
DELISTED
Wireless Telecom Group, Inc.
WTT
| $1.14M | ﹤0.01% |
860,744
-39,492
| -4% | -$59.3K |
|
|
SSKN
2623
DELISTED
Strata Skin Sciences
SSKN
| $1.14M | ﹤0.01% |
118,135
-390
| -0.3% | -$4.63K |
|
2624
Seer Inc
SEER
$116M
| $1.13M | ﹤0.01% |
126,100
-29,400
| -19% | -$269K |
|
|
TE
2625
T1 Energy
TE
$1.41B
| $1.13M | ﹤0.01% |
+164,900
| New | +$1.44M |
|
Similar funds
Jim Simons's Q2 2022 Portfolio in Review
As of Q2 2022, Jim Simons held 4,738 positions worth $84.5B, down 0.87% from $85.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons deployed $13.7B of net new capital in Q2 2022, opening 694 new positions and adding to 1,955 existing holdings. Its largest new stake was Microsoft: 3,820,133 shares worth $981M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Staples.
On the sell side, the largest reduction was Tesla, an estimated $661M trimmed.
- Jim Simons's largest Q2 2022 buy was Microsoft: 3,820,133 shares worth $981M.
- Jim Simons added most to Chevron in Q2 2022, an estimated $820M increase.
- Jim Simons's biggest Q2 2022 reduction was Tesla, cutting an estimated $661M.
- Jim Simons fully exited Amazon in Q2 2022, selling an estimated $675M.
- Jim Simons's ten largest holdings make up 11% of its $84.5B portfolio in Q2 2022.
- Jim Simons opened 694 new positions and closed 562 in Q2 2022.
- Jim Simons's portfolio value fell 0.87% quarter-over-quarter to $84.5B.
Based on Renaissance Technologies's 13F filing for Q2 2022, filed 12 Aug 2022.